Selected books published by thinkBiotech
The leading textbook and primer on the business of biotechnology
From Science to Solutions
Advanced Strategies For Innovative Growth Companies
Showcase your expertise
thinkBiotech publishes the Journal of Commercial Biotechnology, the authorotative source for leading thinking on biotechnology business management. The Journal of Commercial Biotechnology welcomes research papers, case studies, strategic guidance, and industry perspectives. The JCB also welcomes shorter commentaries on industry developments. More details and sample papers are available at http://www.CommercialBiotechnology.com.
BiotechBlog guest posts are available for informative, non-commercial messages. This non-refereed outlet is more inclusive than the Journal of Commercial Biotechnology and is an excellent outlet for your industry perspectives and practical guidance. Submission guidelines are at http://www.biotechblog.com/spread-your-message-with-biotechblog, and existing guest content is at http://www.biotechblog.com/category/guest-content/.
Please send a short pitch using the contact form. Please include a author headshot/company logo and author/company bio for the byline along with any submissions.
thinkBiotech publishes books under the Logos Press imprint. Logos Press specializes in reference and text books addressing the use of knowledge to make intelligent strategic decisions. Recent titles are posted at http://logos-press.com/books/. If you are interested in writing a book or editing a compilation , please check out the submission guidelines at http://logos-press.com/submission.php for guidance.
Yali Friedman, Ph.D., is founder of thinkBiotech and chief editor and publisher of the Journal of Commercial Biotechnology. His book, Building Biotechnology, is used as a course text in dozens of biotechnology programs. His other books include Best Practices in Biotechnology Education and Best Practices in Biotechnology Business Development. He is also a member of the board of directors of AmericasHealth, serves on the science advisory board of Chakra Biotech, is an associate of the World Technology Network, and has also served as a judge for the Biotech Humanitarian Award and the Maryland Incubator Company of the Year Award.
Dr. Friedman has strong exposure to leading issues in international biotechnology. He is lead editorial consultant for Scientific American’s worldVIEW, a global biotechnology perspective profiling biotechnology industries and innovation capacity in dozens of countries, and has been invited to participate in biotechnology industry development forums for international groups such as APEC and for individual countries such as India, Japan, Canada, Germany, the Philippines, and Turkey.
For many years Dr. Friedman taught biotechnology management at the National Institutes of Health and he continues to regularly guest-lecture for other biotechnology education programs. He writes and speaks on diverse topics such as biotechnology entrepreneurship, strategies to cope with a lack of management talent and capital when developing companies outside of established hubs, and new paradigms in technology-based economic development.
Dr. Friedman has a long history in biotechnology media. He created the first blog on the business of biotechnology for a NY Times company, which was named to Forbes “Best of the Web” list. His other projects include the Student Guide to DNA Based Computers, sponsored by FUJI Television, BiotechBlog.com, and DrugPatentWatch.com, a pharmaceutical industry competitive intelligence service based on a business plan that was awarded second place in the Panasci Entrepreneurial Awards Competition.
1133 15th Street Northwest, 12th floor
Washington DC 20005